Cingulate Inc. (CINGW)
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in 2013 and is headquartered in Kansas City, KS.
Address
1901 W. 47TH PLACE
KANSAS CITY, KS 66205
Founded
2013
Number of Employees
13
Website
http://www.cingulate.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)